Skin science article
GHK-Cu: Dosage, Benefits, FDA Status & Clinics (2026)
What Is GHK-Cu? Your body makes this peptide. It's in your blood right now — or at least it was, in much higher concentrations, when you were younger. GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper(II) ions) is a naturally occurring tripeptide that circula
What Is GHK-Cu?
Your body makes this peptide. It's in your blood right now — or at least it was, in much higher concentrations, when you were younger. GHK-Cu (glycyl-L-histidyl-L-lysine bound to copper(II) ions) is a naturally occurring tripeptide that circulates in human serum, saliva, and urine, and it does something unusual: it declines dramatically and measurably with age.[1] At 20, serum GHK levels average around 200 ng/mL. By 60, that's dropped to roughly 80 ng/mL.[1] Researchers have spent decades trying to figure out what that decline actually costs us.
What they've found is that GHK-Cu sits at an unusual intersection of biology. It's not just a collagen booster, though it does stimulate collagen synthesis. It's not just an antioxidant, though it activates antioxidant pathways. A 2018 gene expression analysis found that GHK-Cu appears to reset the gene expression patterns of aged or diseased tissue toward healthier states — upregulating over 30 genes involved in tissue repair and downregulating genes associated with cancer progression and inflammation.[2] That's a striking finding. It's also almost entirely preclinical.
The honest summary: GHK-Cu has some of the most interesting mechanistic data of any peptide in the anti-aging space, and some of the weakest human clinical evidence. If you're considering it, you should understand both halves of that sentence.